SCHEMBL8815345

SCHEMBL8815345

COc1ccccc1CNCc1cccc(-c2cc[nH]n2)c1

nearest known ligand 0.56

Predicted protein targets (top 17)

geneUniProtsupporting neighboursconfidence
KDM4E B2RXH2 3/20 0.56
ALDH1A1 P00352 2/20 0.56
MEN1 O00255 1/20 0.56
KMT2A Q03164 1/20 0.56
BCHE P06276 4/20 0.45
HTR7 P34969 1/20 0.45
LMNA P02545 1/20 0.45
CYP1A2 P05177 1/20 0.45
CYP3A4 P08684 1/20 0.45
CYP2D6 P10635 1/20 0.45
TSHR P16473 1/20 0.45
CYP2C19 P33261 1/20 0.45
CLK4 Q9HAZ1 1/20 0.45
CHRM2 P08172 5/20 0.43
GRIN1 Q05586 3/20 0.43
GRIN2A Q12879 3/20 0.43
ACHE P22303 2/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL8811307 0.83 BCHE (0.45) KDM4EALDH1A1MEN1KMT2ABCHE
SCHEMBL8807896 0.83 MAPT (0.53) KDM4EALDH1A1MEN1KMT2ABCHE
SCHEMBL8808069 0.81 KDM4E (0.53) KDM4EALDH1A1MEN1KMT2ABCHE
SCHEMBL8808848 0.79 SMN1; SMN2 (0.46) ALDH1A1MEN1KMT2ALMNACYP1A2
SCHEMBL8812389 0.76 BCHE (0.50) BCHECYP1A2CYP3A4CYP2D6CYP2C19
SCHEMBL8812666 0.76 NOS1 (0.44) KDM4EALDH1A1MEN1KMT2ALMNA
SCHEMBL27099852 0.75 KDM4E (0.68) KDM4EALDH1A1MEN1KMT2ABCHE
SCHEMBL8883322 0.74 KDM4E (0.70) KDM4EALDH1A1MEN1KMT2ABCHE
Trifluoroacetic Acid SCHEMBL9057618 0.74 HDAC3 (0.41)
SCHEMBL27293615 0.73 LTA4H (0.59) KDM4ELMNATSHRCHRM2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-0784612-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1997-07-23 EP disclosed
WO-1996010559-A1 UREA DERIVATIVES AND THEIR USE AS ACAT-INHIBITORS FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 1996-04-11 WO disclosed